Dermapharm Holding SE Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	144.21	132.41	113.79	62.37	134.24	209.58
Depreciation & Amortization	35.81	35.45	34.93	33.38	23.7	20.66
Other Amortization	44.82	44.82	43.53	52.57	27.73	24.59
Loss (Gain) From Sale of Assets	0.15	1.17	2.72	-2.57	-0.2	-0.4
Asset Writedown & Restructuring Costs	11.74	11.74	8.32	15.82	43.48	9.91
Loss (Gain) on Equity Investments	-4.08	-4.34	-1.52	7.16	13.54	-0.32
Other Operating Activities	18.87	1.58	17.67	41.65	50.18	32.62
Change in Other Net Operating Assets	33.23	6.32	-18.06	9.04	-4.14	-46.27
Operating Cash Flow	284.74	229.15	201.38	219.42	288.53	250.37
Operating Cash Flow Growth	65.05%	13.79%	-8.22%	-23.95%	15.24%	90.98%
Capital Expenditures	-43.89	-42.12	-38.24	-41.54	-39.01	-61.2
Sale of Property, Plant & Equipment	0.61	0.8	3.79	2.82	0.68	2.52
Cash Acquisitions	-48.96	-51.24	-	-389.4	-69.79	-22.51
Investment in Securities	-9.82	-9.82	0.3	7.95	3.93	-48.25
Other Investing Activities	4	4.13	4.53	4.74	5.18	0.1
Investing Cash Flow	-98.06	-98.24	-29.61	-415.43	-99.01	-129.35
Long-Term Debt Issued	-	170	111.17	715	469.95	10
Long-Term Debt Repaid	-	-108.22	-219.3	-420.86	-541.19	-35.91
Net Debt Issued (Repaid)	32.71	61.78	-108.13	294.14	-71.24	-25.91
Common Dividends Paid	-48.46	-48.46	-47.38	-56.53	-116.83	-47.38
Other Financing Activities	-58.96	-59.43	-53.66	-33.07	-11.69	-7.69
Financing Cash Flow	-74.7	-46.11	-209.17	204.54	-199.77	-80.98
Foreign Exchange Rate Adjustments	-1.24	-2.69	-0.04	-0	-0.15	1.07
Miscellaneous Cash Flow Adjustments	0	-	0	-0.83	-	0
Net Cash Flow	110.74	82.12	-37.44	7.7	-10.4	41.11
Free Cash Flow	240.85	187.03	163.14	177.88	249.52	189.17
Free Cash Flow Growth	83.50%	14.64%	-8.29%	-28.71%	31.91%	109.48%
Free Cash Flow Margin	20.37%	15.87%	13.65%	15.46%	23.98%	19.70%
Free Cash Flow Per Share	4.47	3.47	3.03	3.30	4.63	3.51
Cash Interest Paid	51.3	51.77	53.65	33.07	7.76	7.69
Cash Income Tax Paid	64.75	89.89	83.84	65.37	40.59	44.85
Levered Free Cash Flow	160.29	100.96	99.52	106.43	218.88	127.86
Unlevered Free Cash Flow	189.34	131.38	136.03	140.78	226.59	133.38
Change in Working Capital	33.23	6.32	-18.06	9.04	-4.14	-46.27

Source: S&P Global Market Intelligence. Standard template. Financial Sources.